JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Standaert, F. G.
Right arrow Articles by Adams, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Standaert, F. G.
Right arrow Articles by Adams, J. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SUCCINYLCHOLINE
Journal of Pharmacology And Experimental Therapeutics, Vol. 149, Issue 1, 113-123, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


THE ACTIONS OF SUCCINYLCHOLINE ON THE MAMMALIAN MOTOR NERVE TERMINAL

Fhank G. Standaert 1 and John E. Adams 1

1 Department of Pharmacology, Cornell University Medical College, New York, New York

Succinycholine (Sch), which is usually assumed to act exclusively on the postjunetional structures of time neuromuscular junction, profoundly affects the motor nerve terminal. It attenuates posttetanic neural repetitive activity, causes time neural response to a single stimulus to become repetitive, and initiates in time motor nerve action potentials which are independent of an external stimulus. These effects are produced by a wide range of Sch doses, including those well below threshold for blockade of neuromuscular transmission. Provided time dose is kept below the transmission blocking dose, these neural events are fully reflected in muscle electrical and mechanical activity. The fact that Sch affects the motor nerve termninal in much smaller and much larger doses than those which a affect neuromuscular transmission and that, qualitatively, some of these effects are capable of causing trainsmission block suggests that the motor nerve terminal is the primary site of Sch action.

Accepted on February 10, 1965







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.